Overview

Antihistamines in Eosinophilic Esophagitis

Status:
Recruiting
Trial end date:
2021-12-31
Target enrollment:
Participant gender:
Summary
Researchers are assessing the safety and effectiveness of antihistamines in the treatment of eosinophilic esophagitis.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Treatments:
Famotidine
Histamine Antagonists
Histamine H1 Antagonists
Loratadine